Tracy’s current research activity research is concerned with exploring outcomes in clinical areas where valuation is challenging, such as sexually transmitted diseases where the outcomes may be considered temporary for example and also in areas of women’s reproductive health. She is also exploring the utilities and disutility imposed by overdiagnosis in screening programmes. She is interested developing the methodology of economic evaluation to ensure that the benefits of healthcare interventions are more fully captured.

Tracy is involved in leading a wide range of applied economic evaluations many of which are in the areas of sexual health and women’s reproductive health and breast cancer. She has collaborated and is the lead health economist on a wide range of grant-funded projects in these areas.